Stingray Therapeutics announced it raised $437,000 in an initial filing from an offering of $450,000

Feb 02, 2024•almost 2 years ago

Amount Raised

$437,000

Round Type

seed

HoustonBiotechnology

Company Information

Company

Stingray Therapeutics, Inc.

Location

TMCX - TEXAS MEDICAL CENTER ACCELERATOR

Houston, Texas, United States

About

Stingray Therapeutics specializes in identifying targets with untapped potential to modulate the tumor microenvironment.

2 contacts

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech